This inventor holds 1 USPTO granted patent. Top assignee: Mie University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Mano Hasegawa
Introduction
Mano Hasegawa is a notable inventor based in Tsu, Japan. He has made significant contributions to the field of neurodegenerative disease treatment through his innovative research and patents. His work focuses on methods that utilize specific compounds to promote nerve growth and aid in the treatment of various neurological conditions.
Latest Patents
Hasegawa holds a patent for "Methods of treatment and prevention using 4-deoxy-L-erythro-5-hexoseulose uronic acid." This patent describes a method of treating patients by administering a therapeutically effective amount of 4-deoxy-L-erythro-5-hexoseulose uronic acid (DEH). This compound functions as a nerve growth factor (NGF) activity promoter, which is particularly beneficial in treating and preventing neurodegenerative diseases such as PolyQ disease, Parkinson's disease, and Alzheimer's disease.
Career Highlights
Hasegawa is affiliated with Mie University, where he conducts his research and develops his innovative treatments. His work has garnered attention for its potential to improve the quality of life for patients suffering from debilitating neurological disorders.
Collaborations
Hasegawa collaborates with esteemed colleagues, including Toshiyuki Shibata and Hideo Miyake. Their combined expertise enhances the research and development of effective treatments in the field of neurodegenerative diseases.
Conclusion
Mano Hasegawa's contributions to the field of neurodegenerative disease treatment through his innovative patent highlight the importance of research in improving patient outcomes. His work continues to inspire advancements in medical science and offers hope for those affected by these challenging conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile